Halozyme's strategic acquisition of Evotec and innovative ENHANZE technology present growth opportunities. Click here for a ...

ADRs quickly plunged 9% in premarket trading amid a report that the company is preparing to fight back against Halozye ...

Halozyme Therapeutics Inc. plans to finance its €2 billion ($2.1 billion) proposed takeover of Germany’s Evotec SE in cash, ...

智通财经APP获悉，据外媒报道， 奥洛兹美医疗 (HALO.US)首席执行官海伦·托利 (Helen Torley)称，公司计划以现金形式融资20亿欧元 (合21亿美元)收购德国Evotec公司 ...

智通财经APP获悉，据知情人士透露，私募股权公司Triton Partners正在考虑收购德国生物科技公司Evotec (EVO.US)。此前，这家公司已成为Evotec的最大股东之一。

We recently compiled a list of the 10 Best German Stocks To Buy Now. In this article, we are going to take a look at where Evotec SE (NASDAQ:EVO) stands against the other German stocks. In Germany, ...

圣地亚哥 - Halozyme Therapeutics, Inc. (NASDAQ: HALO) 今日宣布计划以每股11.00欧元的价格收购Evotec SE (NASDAQ: EVO)，这笔全现金交易总价值20亿欧元。此次交易旨在打造一家全球领先的制药服务公司，显著扩大和多元化Halozyme的业务范围和财务前景。 这项拟议收购预计将利用Halozyme现有技术和Evotec的平台，创建一个收 ...

Halozyme Therapeutics has bid to buy Evotec for around 2 billion euros ($2.1 billion). Evotec confirmed it received an offer ...

Halozyme Therapeutics (NASDAQ:HALO) announced on Thursday its plans to acquire German drug developer Evotec SE ADR ...

Halozyme Therapeutics (HALO) provided an update on its non-binding proposal to acquire Evotec SE (EVO) for EUR 11.00 per share in cash, ...

圣地亚哥 - Halozyme Therapeutics, Inc. (NASDAQ: HALO)提出了一项非约束性提议,以每股11.00欧元的现金价格收购Evotec SE (NASDAQ: EVO),这将使Evotec的股权价值约为20亿欧元。这一报价相对于2024年10月15日Triton Partners开始累积股份之前的Evotec股价有显著溢价。 此次收购将把Halozyme的药物输送 ...

智通财经APP获悉，据知情人士透露，私募股权公司Triton Partners正在考虑收购德国生物科技公司Evotec(EVO.US)。此前，这家公司已成为Evotec的最大股东之一。